Xultophy Injection
Insulin - Degludec, Liraglutide
"100 Units, 3.6mg/ml"
Novo Nordisk A/S
| Pack size | 3ml Pre-Filled Pens x 5 |
|---|---|
| Dispensing mode | POM |
| Source | DENMARK |
| Agent | CITY MEDICAL STORE |
| Retail Price | 1486.00 AED |
Indications
Xultophy Injection is used for:
The midazolam injection is indicated for preoperative sedation/anziolysis/amnesia. It is also an agent for sedation/anziolysis/amnesia prior to or during diagnostic, therapeutic, or endoscopic procedures. Midazolam can also be given intravenously for induction of general anaesthesia.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Insulin - Degludec, Liraglutide :
Mechanism of Action
It is thought that the actions of benzodiazepines such as midazolam are mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), which is one of the major inhibitory neurotransmitters in the brain. Benzodiazepines increase the activity of GABA, thereby producing a calming effect, relaxing skeletal muscles, and inducing sleep. Benzodiazepines bind to the benzodiazepine site on GABA-A receptors, which potentiates the effects of GABA by increasing the frequency of chloride channel opening.
Note
Xultophy "100 Units, 3.6mg/ml" Injection manufactured by Novo Nordisk A/S. Its generic name is Insulin - Degludec, Liraglutide. Xultophy is availble in United Arab Emirates.
Farmaco UAE drug index information on Xultophy Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.